$INFU
InfuSystem Holdings, Inc

2015 Q2 Form 10-Q Financial Statement

#000119312515183952 Filed on May 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $16.94M $16.73M $17.24M
YoY Change 3.47% -3.0% 17.28%
Cost Of Revenue $4.760M $3.015M $2.890M
YoY Change 63.41% 4.33% 12.06%
Gross Profit $12.18M $12.09M $12.08M
YoY Change 2.16% 0.11% 15.86%
Gross Profit Margin 71.9% 72.28% 70.04%
Selling, General & Admin $9.720M $8.712M $7.564M
YoY Change 29.22% 15.18% 1.68%
% of Gross Profit 79.8% 72.07% 62.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $810.0K $100.0K $100.0K
YoY Change 710.0% 0.0% 0.0%
% of Gross Profit 6.65% 0.83% 0.83%
Operating Expenses $10.53M $10.54M $10.30M
YoY Change 9.86% 2.3% 5.41%
Operating Profit $1.650M $1.552M $1.776M
YoY Change -29.43% -12.61% 172.39%
Interest Expense -$390.0K $672.0K $827.0K
YoY Change -150.26% -18.74% -5.38%
% of Operating Profit -23.64% 43.3% 46.57%
Other Income/Expense, Net $0.00 -$2.252M -$844.0K
YoY Change -100.0% 166.82% 50.18%
Pretax Income $700.0K -$700.0K $932.0K
YoY Change -56.3% -175.11% 935.56%
Income Tax $60.00K -$285.0K $349.0K
% Of Pretax Income 8.57% 37.45%
Net Earnings $640.0K -$415.0K $583.0K
YoY Change -27.77% -171.18% 1043.14%
Net Earnings / Revenue 3.78% -2.48% 3.38%
Basic Earnings Per Share -$0.02 $0.03
Diluted Earnings Per Share $27.18K -$0.02 $0.03
COMMON SHARES
Basic Shares Outstanding 22.36M shares 22.31M shares 21.97M shares
Diluted Shares Outstanding 22.31M shares 22.46M shares

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $800.0K $3.200M $500.0K
YoY Change -20.0% 540.0% 0.0%
Cash & Equivalents $791.0K $3.224M $496.0K
Short-Term Investments
Other Short-Term Assets $1.044M $1.129M $714.0K
YoY Change 46.63% 58.12% -74.5%
Inventory $1.898M $1.979M $1.398M
Prepaid Expenses
Receivables $12.30M $11.50M $12.10M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.29M $20.08M $17.00M
YoY Change 12.19% 18.11% 19.74%
LONG-TERM ASSETS
Property, Plant & Equipment $2.390M $2.457M $915.0K
YoY Change 51.55% 168.52% -94.52%
Goodwill $3.585M
YoY Change
Intangibles $26.58M $25.85M $24.08M
YoY Change 9.46% 7.38%
Long-Term Investments
YoY Change
Other Assets $224.0K $206.0K $238.0K
YoY Change -9.68% -13.45% -98.84%
Total Long-Term Assets $73.49M $67.38M $61.25M
YoY Change 19.63% 10.02% -1.21%
TOTAL ASSETS
Total Short-Term Assets $18.29M $20.08M $17.00M
Total Long-Term Assets $73.49M $67.38M $61.25M
Total Assets $91.78M $87.47M $78.25M
YoY Change 18.07% 11.78% 2.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.306M $5.367M $5.153M
YoY Change 53.77% 4.15% 66.23%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.744M $5.537M $5.305M
YoY Change 74.22% 4.37% 36.03%
Total Short-Term Liabilities $16.24M $13.06M $12.94M
YoY Change 53.99% 0.96% 16.55%
LONG-TERM LIABILITIES
Long-Term Debt $28.03M $28.08M $21.86M
YoY Change 22.8% 28.43% -11.12%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $28.03M $28.08M $21.86M
YoY Change 22.8% 28.43% -11.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.24M $13.06M $12.94M
Total Long-Term Liabilities $28.03M $28.08M $21.86M
Total Liabilities $44.27M $41.14M $34.80M
YoY Change 32.65% 18.22% -2.52%
SHAREHOLDERS EQUITY
Retained Earnings -$43.34M -$44.12M -$46.48M
YoY Change -4.95% -5.08%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.51M $46.33M $43.45M
YoY Change
Total Liabilities & Shareholders Equity $91.78M $87.47M $78.25M
YoY Change 18.07% 11.78% 2.69%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income $640.0K -$415.0K $583.0K
YoY Change -27.77% -171.18% 1043.14%
Depreciation, Depletion And Amortization $810.0K $100.0K $100.0K
YoY Change 710.0% 0.0% 0.0%
Cash From Operating Activities $5.180M -$1.390M -$640.0K
YoY Change 111.43% 117.19% -139.26%
INVESTING ACTIVITIES
Capital Expenditures -$5.800M $3.670M $1.127M
YoY Change -1260.0% 225.64% -163.31%
Acquisitions
YoY Change
Other Investing Activities -$3.030M $1.120M $1.250M
YoY Change -209.78% -10.4% 14.68%
Cash From Investing Activities -$8.830M -$2.550M $130.0K
YoY Change 1258.46% -2061.54% -119.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.220M 6.650M -130.0K
YoY Change -197.6% -5215.38% -95.36%
NET CHANGE
Cash From Operating Activities 5.180M -1.390M -640.0K
Cash From Investing Activities -8.830M -2.550M 130.0K
Cash From Financing Activities 1.220M 6.650M -130.0K
Net Change In Cash -2.430M 2.710M -640.0K
YoY Change -541.82% -523.44% -65.41%
FREE CASH FLOW
Cash From Operating Activities $5.180M -$1.390M -$640.0K
Capital Expenditures -$5.800M $3.670M $1.127M
Free Cash Flow $10.98M -$5.060M -$1.767M
YoY Change 463.08% 186.36% -151.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22359756 shares
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
496000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22506421 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22308730 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2157000
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
5094000
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13061000
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5367000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44119000
CY2015Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3860000
CY2015Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
5537000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
46325000
CY2015Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3981000
CY2015Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
28080000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87466000
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90442000
CY2015Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3907000
CY2015Q1 us-gaap Liabilities
Liabilities
41141000
CY2015Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7145000
CY2015Q1 us-gaap Long Term Debt
LongTermDebt
33617000
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4831000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3224000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3381000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2457000
CY2015Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
43395000
CY2015Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
14143000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2191000
CY2015Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
147000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
7155000
CY2015Q1 us-gaap Assets
Assets
87466000
CY2015Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2252000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4290000
CY2015Q1 us-gaap Inventory Net
InventoryNet
1979000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11498000
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25852000
CY2015Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1129000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
206000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
20082000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2580000
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4255000
CY2015Q1 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2671000
CY2015Q1 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
45849000
CY2015Q1 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
23796000
CY2015Q1 infu Medical Equipment Net
MedicalEquipmentNet
24579000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80213000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90155000
CY2014Q4 us-gaap Liabilities
Liabilities
33761000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
25484000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4739000
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22308730 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
515000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2451000
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
42012000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
13756000
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1194000
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3062000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14729000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5215000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43705000
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6452000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
46452000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19032000
CY2014Q4 us-gaap Assets
Assets
80213000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2252000
CY2014Q4 us-gaap Inventory Net
InventoryNet
1758000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10300000
CY2015Q1 infu Long Term Debt Maturities Repayments Of Principal In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
9630000
CY2015Q1 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
145000
CY2015Q1 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
17543000
CY2015Q1 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
21908000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1138000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22506421 shares
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25073000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
633000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
212000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
15458000
CY2014Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2255000
CY2014Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
43246000
CY2014Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
23311000
CY2014Q4 infu Medical Equipment Net
MedicalEquipmentNet
22069000
CY2014Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
121000
CY2014Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
16940000
CY2014Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
19814000
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2014Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.374 pure
CY2014Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
483404 shares
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-636000
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22456143 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21972739 shares
CY2014Q1 us-gaap Gross Profit
GrossProfit
12076000
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2392000
CY2014Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
14394000
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
17242000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
932000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1776000
CY2014Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14850000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-844000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1127000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
583000
CY2014Q1 us-gaap Interest Expense
InterestExpense
827000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
10300000
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2655000
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2890000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2107000
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
629000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-642000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
349000
CY2014Q1 us-gaap Depreciation
Depreciation
100000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-131000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
125000
CY2014Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1252000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4909000
CY2014Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
14263000
CY2014Q1 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
700000
CY2014Q1 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
2276000
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
CY2015Q1 dei Trading Symbol
TradingSymbol
INFU
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.408 pure
CY2015Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
446283 shares
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1392000
CY2015Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2020-03-23
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22308730 shares
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001337013
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22308730 shares
CY2015Q1 us-gaap Gross Profit
GrossProfit
12089000
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1586000
CY2015Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
38633000
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
16725000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1552000
CY2015Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
15139000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2252000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-700000
CY2015Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
147000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3670000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-415000
CY2015Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1599000
CY2015Q1 us-gaap Interest Expense
InterestExpense
672000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
10537000
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2737000
CY2015Q1 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1621000
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3015000
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1194000
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
631000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2709000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-285000
CY2015Q1 us-gaap Depreciation
Depreciation
100000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6653000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2552000
CY2015Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1118000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5975000
CY2015Q1 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
45980000
CY2015Q1 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1000000
CY2015Q1 infu Principal Payments On Capital Lease Obligations
PrincipalPaymentsOnCapitalLeaseObligations
547000

Files In Submission

Name View Source Status
0001193125-15-183952-index-headers.html Edgar Link pending
0001193125-15-183952-index.html Edgar Link pending
0001193125-15-183952.txt Edgar Link pending
0001193125-15-183952-xbrl.zip Edgar Link pending
d922316d10q.htm Edgar Link pending
d922316dex101.htm Edgar Link pending
d922316dex102.htm Edgar Link pending
d922316dex103.htm Edgar Link pending
d922316dex104.htm Edgar Link pending
d922316dex311.htm Edgar Link pending
d922316dex312.htm Edgar Link pending
d922316dex321.htm Edgar Link pending
d922316dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g922316ex10_1pg001.jpg Edgar Link pending
g922316ex10_1pg094a.jpg Edgar Link pending
g922316ex10_1pg094b.jpg Edgar Link pending
g922316ex10_1pg094c.jpg Edgar Link pending
g922316ex10_1pg094d.jpg Edgar Link pending
g922316ex10_1pg094e.jpg Edgar Link pending
g922316ex10_1pg094f.jpg Edgar Link pending
g922316ex10_1pg096a.jpg Edgar Link pending
g922316ex10_1pg128a.jpg Edgar Link pending
g922316ex10_1pg128b.jpg Edgar Link pending
g922316ex10_1pg128c.jpg Edgar Link pending
g922316ex10_1pg128d.jpg Edgar Link pending
g922316ex10_1pg128e.jpg Edgar Link pending
g922316ex10_1pg128f.jpg Edgar Link pending
g922316ex10_1pg131a.jpg Edgar Link pending
g922316ex10_1pg131b.jpg Edgar Link pending
g922316ex10_1pg131c.jpg Edgar Link pending
g922316ex10_1pg131d.jpg Edgar Link pending
g922316page002.jpg Edgar Link pending
infu-20150331.xml Edgar Link completed
infu-20150331.xsd Edgar Link pending
infu-20150331_cal.xml Edgar Link unprocessable
infu-20150331_def.xml Edgar Link unprocessable
infu-20150331_lab.xml Edgar Link unprocessable
infu-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending